Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: A retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG)

By Venderbosch Sabine   Doornebal Joan   Teerenstra Steven   Lemmens Wim   Punt Cornelis J. A.   Koopman Miriam  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 831-839

Informa Healthcare

Access to resources Recommend Favorite

Systemic treatment of colorectal cancer

By Tebbutt N.C.   Cattell E.   Midgley R.   Cunningham D.   Kerr D.  

European Journal of Cancer, Vol. 38, Iss. 7, 2002-05 ,pp. : 1000-1015

Elsevier

Access to resources Recommend Favorite

Bevacizumab in the treatment of metastatic colorectal cancer

By Caprioni Francesco   Fornarini Giuseppe  

Future Oncology, Vol. 3, Iss. 2, 2007-04 ,pp. : 141-148

Future Medicine

Access to resources Recommend Favorite

Recent Advances in the Systemic Therapy of Metastatic Colorectal Cancer

By Jefford Michael   Zalcberg John  

American Journal of Cancer, Vol. 4, Iss. 1, 2005-01 ,pp. : 15-34

Adis International

Access to resources Recommend Favorite

Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 9, 2013-11 ,pp. : 1344-1353

Bentham Science Publishers

Access to resources Recommend Favorite